(Q42435785)
Statements
1 reference
Phase 1 evaluation of intralesionally injected TLR9-agonist PF-3512676 in patients with basal cell carcinoma or metastatic melanoma (English)
1 reference
Maja A Hofmann
1 reference
Christian Kors
1 reference
Heike Audring
1 reference
Peter Walden
1 reference
Wolfram Sterry
1 reference
Uwe Trefzer
1 reference
1 June 2008
1 reference
1 reference
31
1 reference
5
1 reference
520-527
1 reference
Identifiers
1 reference
1 reference